Spirospermum penduliflorum Thouars (Menispermaceae) is widely used on the eastern coast of Madagascar to treat hypertension. The aim of the present study was to analyse the vasorelaxant properties of different leaf extracts. The activity of the n-hexane, dichloromethane and methanolic extracts was tested on phenylephrine-contracted aorta. The dichloromethane extract was shown to be the most effective. Further fractionation of this extract led to the isolation of an active fraction relaxing phenylephrine-contracted aorta with an IC 50 of 0.18 µg/mL {log IC 50 (µg/mL) -0.74 ± 0.03} but was much less effective on KCl induced contractions. Bioassay-guided fractionation of this fraction led to the isolation of two aporphinoid alkaloids, neolitsine and dicentrine, which at concentrations of 0.1 µM and 1 µM displaced to the right the phenylephrine concentration-contraction curve. Our results show that Spirospermum penduliflorum extracts possess vasorelaxant activity in vitro that could be related to the presence of dicentrine in the extracts having an  1 antagonist activity. This finding is not in accord with the previous studies by Rasoanaivo et al. where no alkaloids were detected in the leaves of Spirospermum penduliflorum.
Madagascar is one of the lands where traditional medicine based on the use of plants has an important place in society. Several plants in the Malagasy flora are alleged to possess therapeutic virtues and are largely used by the local population. Many of these plants are used without pharmacological or phytochemical data or clinical evaluation. Our studies lead us to investigate plants used for the treatment of hypertension. Among these, Spirospermum penduliflorum (Menispermaceae) is mentioned to be effective against arterial hypertension. The aim of the present study was to verify the traditional use of the plant and to determine the nature of the bioactive compounds by a bio-guided fractionation approach combining chromatographic methods with vasorelaxant activity tests.
When tested on phenylephrine-contracted aorta (Figure 1 ), the nhexane, dichloromethane (DCM) and methanol (MeOH) extracts showed significant vasorelaxant activity characterized by log IC 50 (µg/mL) values of 1.4 ± 0.02, < -0.5 and 0.29 ± 0.01, respectively (respective IC 50 values were 25 µg/mL, < 0.3 µg/mL and 1.9 µg/mL). Isoprenaline, used as a reference standard, exhibited vasorelaxant activity with an IC 50 of 1.7 µg/mL. Fractionation of the dichloromethane extract was then undertaken by preparative TLC giving 4 fractions named RR, RR 1 , RR 2 and RR 3 . Each fraction was tested at 1 µg/mL for its vasorelaxant activity on rat aorta contracted by phenylephrine (Table 1) . RR 1 showed the highest vasorelaxant activity, which was further investigated. The relaxation of phenylephrine-induced contraction by RR 1 was tested in rat aorta with (E+) and without endothelium (E-). Figure  2A shows that the activity of RR 1 was not significantly different in either the presence or absence of functional endothelium: the log IC 50 values (µg/mL) were -0.74 ± 0.03 and -0.61 ± 0.02 in the presence and absence of endothelium, respectively (IC 50 values were 0.18 and 0.24 µg/mL) (p > 0.05, n = 6). To determine the potential role of β-adrenergic receptors in the vasorelaxant effect of RR 1 , aorta rings were pre-incubated with propranolol (1 µM) before the contractile response to phenylephrine. Figure 2A shows that propranolol did not affect the vasorelaxant activity of RR 1 . Log IC 50 (µg/mL) of RR 1 in the presence of propranolol was -0.54 ± 0.02 (0.29 µg/mL).
The potential involvement of voltage-dependent Ca 2+ channels (VDCs) in the relaxing activity of RR 1 was tested by measuring the effect of RR 1 on KCl-induced contraction. When KCl (100 mM) was used to evoke the contraction of the aorta, RR 1 produced a concentration-dependent relaxation. However, RR 1 was less potent in inhibiting KCl-contraction than phenylephrine-contraction ( Figure 2B ). The IC 50 value for KCl-contraction was higher than 30 µg/mL (n = 6).
The developed TLC chromatogram of RR1 showed two well separated spots at Rf 0.62 and 0.81, which gave positive reactions with Dragendorff's reagent. Fractionation by successive open column chromatography, followed by purification on preparative TLC led to the isolation of two active compounds, 1 and 2.
Comparison of our spectroscopic and mass spectrometric data with those in the literature, and with a reference sample, led us to the identification of compound 1 as dicentrine [1, 2] , and compound 2 as neolitsine [2] .
Because of the small amount of neolitsine that could be isolated, the determination of its pharmacological profile was not possible. Dicentrine was tested for its relaxing activity on phenylephrineinduced contraction in endothelium-denuded artery rings. As shown in Figure 3A , preincubation of the aorta with dicentrine shifted the concentration-contraction curve of phenylephrine to the right, in a concentration-dependent manner. The EC 50 value of phenylephrine was significantly increased from 12 nM to 52 nM and 341 nM in the absence and in the presence of 0.1 µM and 1 µM of dicentrine, respectively (logEC 50 values were -7.9 ± 0.02 in control aorta, -7.14 ± 0.05 and -6.47 ± 0.03, in the presence of 0.1 µM and 1 µM dicentrine, respectively, p < 0.05 dicentrine vs control). Dicentrine also relaxed aorta pre-contracted with phenylephrine, with a logIC 50 (M) value of-5.53 ± 0.05 (IC 50 value was 2.95 µM) ( Figure 3B ).
High blood pressure represents the main cause of death in the world. A recent study in 2009 on the prevalence of hypertension in Antananarivo, Madagascar revealed that 28.0 % of the adult population suffer from this disease with a mean age of 49 years. High blood pressure prevalence increased from 19.1 % in 2000 to 28.0 % in 2009 in Antananarivo [3] .
Traditional phytomedical practice is common in Madagascar and Spirospermum penduliflorum is used as a traditional medicine to treat hypertension. We showed here that crude extracts of its leaves exhibited significant concentration-dependent relaxation on rat aorta pre-contracted by phenylephrine, the dichloromethane extract being the most effective (IC 50 < 0.3 µg/mL). We further studied the mechanism of action of the most active fraction (RR 1 ) after a first fractionation of this extract. We found that the vasorelaxant activity was not inhibited by the β-adrenergic antagonist propranolol indicating that the active compound(s) relaxed rat aorta by a mechanism other than the stimulation of the β-adrenergic receptor.
When vasoconstriction was evoked by KCl (100 mM), RR 1 was markedly less active than on phenylephrine pre-contracted aorta. This reduced relaxant activity of RR 1 on KCl-induced contraction indicates that its activity is not related to inhibition of VDCs but to an   adrenergic receptor inhibition. Vasorelaxant activity can also be mediated by an effect of endothelium-released nitric oxide (NO).
We observed that the activity on RR 1 was not affected by removing the endothelium, indicating that endothelial NO does not contribute to the effect of RR 1 .
Bioguided fractionation of the RR 1 fraction led to the isolation of two aporphine alkaloids identified as dicentrine and neolitsine. Indeed, the Menispermaceae family is known to be a rich source of aporphine alkaloids [4] [5] [6] . Previous studies of the root bark of Spirospermum penduliflorum have shown the presence of the bisbenzylisoquinoline alkaloids limacine and palmitine, and aporphine alkaloids [7, 8] . The authors mentioned that they did not detect alkaloids in the leaves. That was not corroborated by our study. It is well known that production of secondary metabolites such as alkaloids is influenced by numerous factors such as the age of the plant or the leaves, and the nutrients present in the soil [9] . The influence of factors on alkaloid production could be the cause of this discordance, probably linked to the sensitivity of the detection method used.
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In agreement with the interaction of the RR 1 fraction with the adrenergic pathway, dicentrine induced a concentration-dependent parallel shift of the phenylephrine concentration-contraction curve, suggesting that it could act as an antagonist of the α 1 -adrenergic receptor. This result is in accordance with those reported in the literature. Indeed, a previous study on dicentrine isolated from Lindera megaphylla showed that it is an α 1 -adrenoreceptor competitive antagonist [10] . Other studies on dicentrine corroborated this allegation [11, 12] . Literature data also report that neolitsine is a potent vasorelaxing agent on precontracted rat aorta preparations [13] . The presence of dicentrine and neolitsine may support the use of the plant as an antihypertensive, but standardisation is necessary as it seems that the alkaloid concentration may be highly variable; such a quality control method has recently been described [14] . However, the total safety of the use of the plant is uncertain because dicentrine and neolitsine were shown to be cytotoxic [15] [16] [17] , and so further toxicological studies are needed.
Experimental
Plant material: Fresh leaves of Spirospermum penduliflorum were collected from the east coast of Madagascar. Botanical identification was made by the botanist Benja Rakotonirina. A voucher specimen was deposited at the herbarium of IMRA (n° AML13).
Chemical compounds:
The following reagents were purchased from Sigma (St Louis, MO): isoprenaline, acetylcholine, D-glucose, phenylephrine, propranolol, prazosin, dimethylsulfoxyde and Nnitro-L-arginine. L-Dicentrine was purchased from Sequoia Research Products (Pangbourne, UK). Methanol, ethylacetate, and dichloromethane were purchased from Scharlab (Barcelona, Spain). All the salts (KCl, NaCl, NaHCO 3 , MgCl 2, and CaCl 2 ) were purchased from Prolabo (VWR international, Haasrode, Belgium).
Extraction:
The plant material used was in the form of finely ground, dried leaves. Extraction was performed by successive maceration of the plant material (750 g) in increasing polarity solvents, namely n-hexane, dichloromethane, and methanol (2.5 L of each). The extracts were filtered and dried under reduced pressure.
Rat aorta: Wistar rats of either sex weighing between 200 to 300 g were used in the study. Animals were sacrificed, the thoracic aorta isolated and cut into rings of 2 mm in length. The rings were mounted under a tension of 2g in organ baths containing Krebs solution (NaCl 122 mM, KCl 5.9 mM, NaHCO 3 15 mM, MgCl 2 1.25 mM, CaCl 2 1.25 mM, and glucose 11 mM). When required, the endothelium was removed from the rat aorta rings by gently rubbing the luminal surface with a cotton rod before mounting the aorta ring in the organ bath. The bath solution was maintained at 37°C and gassed with 95% O 2 and 5% CO 2 . Aorta were equilibrated in the medium for 2 h and the bath solution was changed every 30 min. After 1 h of equilibration, the tension was adjusted to 2 g. Contractions and relaxations were recorded with an Ugobasile 7003 isometric force transducer. All experiments were performed in accordance with international guidelines and the local ethics committee.
Pharmacological experiments Relaxing activity on the contraction induced by phenylephrine:
The relaxing activity was tested on phenylephrine pre-contracted aorta either in the absence or presence of endothelium. In both cases, after the equilibration, phenylephrine (1 µM) was added to the organ bath (20 mL) to induce contraction. At the steady-state contraction, acetylcholine (1 µM) was injected into the bath solution to relax the aorta in order to verify the presence of endothelium and its integrity. After 60 min of recuperation time, the artery rings were stimulated with phenylephrine (1 µM) and cumulative concentrations of the extracts (from 0.3 to 50 µg/mL), from a stock solution in DMSO/H 2 O (10:90: v/v) were added into the organ bath (20 mL) at the steady-state of contraction to evaluate the vasorelaxant activity. When required, aorta rings were incubated in the presence of propranolol (1 µM) for 30 min before inducing the contraction with phenylephrine. 
Relaxing activity on KCl induced contractions:

Identification method:
Identification of the isolated compounds was performed with a LCQ Advantage Thermo Finnigan (Waltham, MA, USA) mass spectrometer piloted by X-Calibur software. Mass spectra were determined using an APCI source in positive mode, a vaporizer temperature of 455°C, a sheath gas flow rate of 45 (a.u.) and a capillary voltage of 2V. 13 C and 1 H NMR spectra were recorded on a Bruker Avance DRX-400 spectrometer in CDCl 3 , CD 3 OD or DMSO at 400 MHz ( 1 H) and 100 MHz ( 13 C), at 30°C. A combination of COSY, HMQC, HMBC and ROESY experiments were used when necessary for the assignment of 1 H and 13 C chemical shifts.
Statistical analysis:
The relaxant effect of the tested products was expressed as percent of the steady-state contraction induced by the agonist or the KCl-depolarizing solution. The log values of EC 50 , which is defined as the concentration producing 50% of the maximum response, or of IC 50 (concentration inhibiting the contraction by 50%) were determined from the non-linear
